Empowered Funds LLC trimmed its position in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 66.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 63,743 shares of the company’s stock after selling 127,491 shares during the quarter. Empowered Funds LLC owned approximately 0.14% of Avanos Medical worth $1,532,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in AVNS. KBC Group NV lifted its stake in Avanos Medical by 63.0% in the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after buying an additional 1,095 shares during the period. Canada Pension Plan Investment Board purchased a new position in Avanos Medical in the second quarter worth $70,000. EntryPoint Capital LLC increased its holdings in Avanos Medical by 97.6% during the first quarter. EntryPoint Capital LLC now owns 5,601 shares of the company’s stock worth $112,000 after buying an additional 2,766 shares during the last quarter. XTX Topco Ltd purchased a new position in Avanos Medical in the second quarter valued at approximately $202,000. Finally, Magnetar Financial LLC purchased a new stake in Avanos Medical in the 2nd quarter worth about $248,000. 95.17% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.
Avanos Medical Stock Performance
Shares of NYSE AVNS opened at $18.02 on Friday. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. The stock has a market cap of $828.20 million, a price-to-earnings ratio of 54.00 and a beta of 0.92. The stock’s 50-day moving average is $21.95 and its 200 day moving average is $21.56. Avanos Medical, Inc. has a 1-year low of $17.39 and a 1-year high of $25.36.
Avanos Medical Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
- Five stocks we like better than Avanos Medical
- Why Are These Companies Considered Blue Chips?
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- How to Plot Fibonacci Price Inflection Levels
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- TJX Companies Stock Poised to Hit a New High This Year
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Free Report).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.